Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 7.52 B8.52 B8.74 B9.88 B 34.67 B Research & development 8.15 B8.5 B8.91 B10 B 35.56 B Operating income 37.96 B38.27 B38.4 B40.6 B 155.24 B Non-Operating Income, Total -3.66 B9.97 B942 M3.44 B 10.7 B Interest expense, net of interest capitalized 698 M736 M778 M839 M 3.05 B Non-Operating Income, excl. Interest Expenses 1.26 B430 M1.43 B2.85 B 5.97 B Unusual income/expense -4.92 B9.54 B-491 M595 M 4.72 B Pretax income 34.3 B48.25 B39.34 B44.05 B 165.93 B Equity in earnings ———— — Taxes 6.55 B9.79 B7.56 B8.28 B 32.19 B Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 27.75 B38.46 B31.78 B35.77 B 133.75 B Discontinued operations ———— — Net income 27.75 B38.46 B31.78 B35.77 B 133.75 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 27.75 B38.46 B31.78 B35.77 B 133.75 B Basic earnings per share (Basic EPS) 3.735.184.284.81 18 Diluted earnings per share (Diluted EPS) 3.725.164.274.8 17.95 Average basic shares outstanding 7.43 B7.43 B7.43 B7.43 B — Diluted shares outstanding 7.47 B7.46 B7.45 B7.45 B — EBITDA 47.73 B48.65 B49.9 B57.15 B 203.44 B EBIT 37.96 B38.27 B38.4 B40.6 B 155.24 B Cost of revenue 24.04 B25.98 B26.83 B29.52 B 106.37 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 9.77 B10.38 B11.51 B16.55 B 48.2 B